5/3
06:35 am
nvs
Fragile X Syndrome Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status [Yahoo! Finance]
Low
Report
Fragile X Syndrome Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status [Yahoo! Finance]
5/2
08:55 am
nvs
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion [Yahoo! Finance]
Low
Report
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion [Yahoo! Finance]
5/2
07:50 am
nvs
Novartis to buy Mariana Oncology for $1B upfront [Seeking Alpha]
Low
Report
Novartis to buy Mariana Oncology for $1B upfront [Seeking Alpha]
5/2
07:13 am
nvs
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer [Yahoo! Finance]
Low
Report
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer [Yahoo! Finance]
5/2
06:32 am
nvs
The Global Market for Smart Inhalers, 2018-2023 and 2024-2033 - Novartis, AstraZeneca, GlaxoSmithKline, 3M Health Care, and Boehringer Ingelheim International Dominate the $1.62 Billion Industry [Yahoo! Finance]
Low
Report
The Global Market for Smart Inhalers, 2018-2023 and 2024-2033 - Novartis, AstraZeneca, GlaxoSmithKline, 3M Health Care, and Boehringer Ingelheim International Dominate the $1.62 Billion Industry [Yahoo! Finance]
5/2
03:08 am
nvs
Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing [Yahoo! Finance]
Low
Report
Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing [Yahoo! Finance]
5/1
08:41 am
nvs
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors [CNBC]
Low
Report
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors [CNBC]
4/30
11:04 am
nvs
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
4/30
07:10 am
nvs
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis [Yahoo! Finance]
Low
Report
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis [Yahoo! Finance]
4/30
07:00 am
nvs
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
Low
Report
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
4/30
06:36 am
nvs
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG [Yahoo! Finance]
Low
Report
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG [Yahoo! Finance]
4/30
06:33 am
nvs
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG [Financial Post (Toronto, Ontario, Canada)]
4/30
03:37 am
nvs
Sandoz, Amgen reach agreement resolving patent litigation over biosimilars [Seeking Alpha]
Low
Report
Sandoz, Amgen reach agreement resolving patent litigation over biosimilars [Seeking Alpha]
4/30
01:36 am
nvs
Sandoz reaches agreement with Amgen over patent dispute [Yahoo! Finance]
Low
Report
Sandoz reaches agreement with Amgen over patent dispute [Yahoo! Finance]
4/30
01:16 am
nvs
Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars [Yahoo! Finance]
Low
Report
Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars [Yahoo! Finance]
4/30
01:09 am
nvs
Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars [Financial Post (Toronto, Ontario, Canada)]
4/29
12:05 pm
nvs
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding [Yahoo! Finance]
Low
Report
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding [Yahoo! Finance]
4/29
11:54 am
nvs
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
4/29
10:38 am
nvs
CAR T-Cell Therapy Market to Reach Valuation of USD 22.2 Billion By 2032: Astute Analytica [Yahoo! Finance]
Low
Report
CAR T-Cell Therapy Market to Reach Valuation of USD 22.2 Billion By 2032: Astute Analytica [Yahoo! Finance]
4/29
04:03 am
nvs
Cell and gene therapy companies trip at scalability hurdle [Yahoo! Finance]
Low
Report
Cell and gene therapy companies trip at scalability hurdle [Yahoo! Finance]
4/26
07:08 am
nvs
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies and Better Predict Human Outcomes for Age-Related Diseases [Yahoo! Finance]
Low
Report
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies and Better Predict Human Outcomes for Age-Related Diseases [Yahoo! Finance]
4/25
09:07 am
nvs
20 Countries with the Highest Rates of Stomach Cancer in the World [Yahoo! Finance]
Low
Report
20 Countries with the Highest Rates of Stomach Cancer in the World [Yahoo! Finance]
4/24
11:33 am
nvs
Novartis AG (NYSE: NVS) had its price target raised by analysts at BMO Capital Markets from $114.00 to $116.00. They now have a "market perform" rating on the stock.
Low
Report
Novartis AG (NYSE: NVS) had its price target raised by analysts at BMO Capital Markets from $114.00 to $116.00. They now have a "market perform" rating on the stock.
4/24
01:35 am
nvs
Roche Sales Decline in Last Quarter of Pandemic Impact [BNN Bloomberg (Canada)]
Low
Report
Roche Sales Decline in Last Quarter of Pandemic Impact [BNN Bloomberg (Canada)]
4/24
12:33 am
nvs
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria [Yahoo! Finance]
Low
Report
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria [Yahoo! Finance]